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This study described changes in the
characteristics of a transplantable murine
myelogenous leukemia (C1498) since its
initial isolation in 1941. Demonstration
of C-type "virus" particles, ability to
maintain the disease as an ascites tumor
with single cell preparations and ability
to cause development of the disease by
injection of peripheral blood leukocytes
support the original identification of the
disease as a leukemia. Characteristic
anemia was seen without a corresponding
steady granulocytosis. The leukocyte
counts exhibited cycling and at least
two distinct causes of death were sus-
pected. The tumor is surrounded by a
fibrous capsule suggesting a rejection
phenomenon. Large numbers of mor-
phologically mature granulocytes were
found in the blood throughout the dis-
ease course, although the number of im-
mature forms increased steadily as the
disease progressed. Granulocytic infil-
tration of the spleen and liver was
evident and growth of the tumor when
transplated under aseptic conditions was
certain. It is suggested that the recipient
mice showed increased recognition of tu-
mor cells because inflammatory and
immune responses to the invading cells
increased. It appears that the char-
acteristics of a true myelogenous leukemia
are masked by the presence of an inflam-
matory response in the host C571B1/6J
mouse strain.
On September 5, 1975, Jim Graham succumbed
to the disease he so diligently investigated.
The changed disease course and pathol-
ogy of C1498 murine myelogenous leu-
kemia are of particular interest for a
variety of reasons. It was shown that
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"C-type" particles can be found in the
subcutaneous tumor occurring after
transplant of the leukemic cells, although
a causal relationship has not been demon-
strated (Graham and Crang, 1971).
The C1498 leukemia has also been used
in the study of the effects of granulo-
poietic control substances on murine
myelogenous leukemia (McMahon, 1972;
Graham and McMahon, 1973; Graham,
1973). Although lymphocytic leukemias
are common in rodents, the C1498 variety
is one of only five rodent myelogenous
leukemias (compared with 17 lympho-
genous) described in the compendium of
transplantable tumors by Dunham and
Stewart (1953). It should be added that
recently, virally-induced myelogenous
leukemias have been reported, including
the isolation of a myelogenous leukemia-
inducing virus (MyLV) from a chloro-
leukemia cell line originally induced in
C57B1 mice by the Friend virus complex
(McGarry, et al., 1974).
The tumor we studied was in approxi-
mately its 1,225th passage when brought
to Bowling Green after original identifica-
tion by J. Brandenberg at the University
of California in 1941, and transferred to
Jackson Laboratory in 1949 (Jackson,
1968). Since 1970, the tumor has been
passaged more than 50 times in our
laboratory. The gross appearance of the
tumor has remained unchanged (Dunham
and Stewart, 1953; Jackson, 1968), al-
though marked differences in the disease
course and hematologic symptoms were
found. Tumor cells were transplanted
into the axillary region of the host mouse
by trochar with 100 percent takes pro-
ducing a palpable tumor 5-7 days after
implantation. It appears as a mass of
dark red hemorrhagic tissue closely at-
tached to the skin.
The primary hematologic symptom of
the C1498 leukemia was the observation
of lack of granulocytic differentiation
(Jackson, 1968). We observed major
No. 4 MURINE MYELOGENOUS LEUKEMIA 203
changes in the hemotologic response to
implantation of the tumor cells. The
most startling was the high degree of
granulocytic maturation found, including
large numbers of fully segmented neutro-
phils. Other significant changes in the
disease course and in histologic observa-
tions may explain the dramatic dif-
ferences found in hematologic values.
METHODS
The tumor used in this study was the myelo-
genous leukemia C1498, which is carried in the
C57B1/6J inbred mouse strain. Both the tu-
mor and the host mice were originally obtained
from the Jackson Laboratory, Bar Harbor,
Maine.
The 10-day-old tumor bearing mice were
sacrificed, and the tumors were removed and
finely minced in sterile saline. Cell viability
of the minced tumor was determined by the
trypan blue dye exclusion method and was al-
ways found to be greater than 99%. The
minced tumor-saline solution was injected
aseptically by trochar into the axillary region
of the recipient mice as a subcutaneous inocula-
tion. No signs of ill effects or infection arising
from the inoculation were seen. The tumor-
bearing mice were kept in constant temperature
and humidity in an environmental chamber,
and provided with food and water ad libitum.
In all experiments, male and female mice six
weeks of age and older were selected at random
from the breeding colony.
Blood was taken from the tail vain and col-
lected in a small vial containing 0.2 mg/ml
blood of ethylene diamine tetraacetic acid,
disodium salt (EDTA). Total erythrocyte
and leukocyte counts were done on a Model B,
Coulter Counter (Graham and Morrison, 1970).
Additional blood was obtained from the tail
vein, placed in a heparinized capillary tube and
centrifuged at 13,500 RPM for three minutes to
obtain the packed cell volume (hematocrit).
Leukemic animals were sampled on the sixth,
eighth, twelfth and eighteenth days post-im-
plantation. Normal mice were sampled on the
same day the tumor was implanted into the
experimental mice. Twenty animals were used
at each of these sampling points.
Peripheral blood differential counts were
made from smears stained with Jenner-Giemsa
(Morrison, 1967). Identification of granulo-
cytes was done according to the compartment
concept of Boggs, et al. (1965). Classification
of the main groups of the erythroid, lymphoid
and other cell types was based on Harris and
Burke (1957) and Morrison (1967).
Spleen, thymus, liver and tumor tissues were
obtained immediately after natural death of
the leukemic mice and fixed in a formalin-acetic
alcohol fixative for 24 hours. Tissues were
drained and placed in automated butyl
alcohol-dehydration and paraffin-infiltration
series. The individual dehydrated and infil-
trated tissues were embedded in 56°C Para-
plast (Sherwood Medical Industries, Inc.).
The blocks were cooled and cut into 8-10 micron
sections and placed on slides coated with
gelatin adhesive. The finished slides were
dried for 2-3 hours on a heating plate at 43°C
before staining with hematoxylin and eosin. A
one-way analysis of variance with repeated
measures was done by computer to measure the
significance of the erythrocyte, hematocrit,
total leukocyte and differential leukocyte
counts.
RESULTS
The time of death of nearly 200 un-
treated leukemic mice are presented in
figure 1. The number of mice that died
on each day of post-tumor implantation
resulted in bi-modal distribution rather
than a bell shaped curve. The erythro-
cyte counts for untreated leukemic mice
dropped throughout the course of the
disease (fig. 2, left). It should be noted
that the largest drop occurred between
the 8th and 12th days. The range of
values at each sampling day are shown
with the superimposed black bar and it is
evident that the range of the counts
broadened with the passage of time. The
hematocrit values (fig. 2, center) showed
the same pattern as the erythrocyte
counts with the range of values at a
particular sampling point increased from
0 to 18 days.
The total leukocyte counts for un-
treated leukemic mice are shown in
figure 2, right. The average count did
not increase consistently as the disease
progressed. In fact, the average count
increased by 6 days post-injection, dropped
at 8 days and again rose at 12 days. It
should also be noted that the ranges
were in all cases very large, particularly
at 6 and 12 days.
The percentage and absolute cell counts
for early granulocytes seen in figure 3,
top, showed the same pattern as the total
leukocyte count with low values. The
intermediate granulocytes followed this
same trend (fig. 3, center). The absolute
cell count for the mature granulocytes
showed a consistent increase from 0 to
18 days, while the percentage of mature
granulocytes at 6 and 8 days was lower
than that at 0 days (fig. 3, bottom).
The percentage of eosinophils greatly
decreased at all four post-implantation
sampling points when compared to the
inital days value. The only significant
change in the absolute cell count of
eosinophils was the four-fold increase at
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FIGURE 1. Time of death of mice implanted with the C1498 leukemia tumor. The bimodal distri-
bution differs from the expected bell-shaped curve.
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FIGURE 2. Erythrocyte, hematocrit and. total leukocyte values (left to right) for leukemic mice at
G, 8, 12 and 18 days post-tumor implantation.
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FIGURE 3. Percentage and absolute number of
early, intermediate, and mature
granulocytes (top-bottom) in the
blood of leukemic mice after tumor
implantation.
12 days (fig. 4, top). The percentage of
lymphocytes dropped drastically (to one
half) from 0 to 6 days and stayed at this
low level through to the eighteenth day.
The absolute cell count of lymphocytes
increased significantly at 6, 8 and 12
days post-tumor implantation (fig. 4,
bottom).
The differential leukocyte counts found
at each of the four sampling points (6, 8,
12 and 18 days post-tumor implantation)
FIGURE 4. Percentage and absolute number of
eosinophils (top) and lymphocytes
(bottom) in the blood of leukemic
mice after tumor implantation.
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were compared with standard values
obtained from the literature (table 1).
Peripheral counts are extremely variable
in the leukemic mice and it was impossible
to demonstrate statistically significant
changes in numbers of the various cell
types. The total granulocyte values of
25% at 6 days, 37% at 8 days, 41% at
12 days, and 69% at 18 days suggest an
increasing granulocytosis, when com-
pared with the normals of 28% to 28.5%
reported by Scarborough (1931) and
Petri (1933). Examination of peripheral
blood films revealed a large number of
morphologically mature segmented neu-
trophils (50% at 18 days) as well as
relatively fewer (15.5%) metamyelocytes
and ring or stab forms. The cells did
not differ from neutrophils obtained from
normal mice.
at the time of death of the mice was also
seen. Granulocytic cells were seen sur-
rounding the blood vessels of the liver.
Degree of involvement as measured by
the relative number of granulocytic cells
surrounding the capillaries varied but
was found in nearly all mice by the time
of death. Splenomegaly was frequently
evident but rarely exceeded a 50% in-
crease over the average spleen weight of
control mice (0.06 gms). Some invasion
of the red pulp of the spleen was regularly
seen and the distinctiveness of the red
and white pulp was blurred by the
granulocytic infiltration. The splenic
capsule was often also invaded by gran-
ulocytic cells. No significant involve-
ment of the thymus was apparent.
The results of this study demonstrate
the complexities involved in the use of
TABLE 1
Comparison of peripheral leukocyte counts from leukemic and normal mice.
Cell Type
Early Granulocyte
Int. Granulocyte
Mature Granulocyte
Eosinophil
TOTAL GRANULOCYTES
Lymphocytes
Monocytes
% Normal
Value* From
Literature
2.0
28
65-68
7-7.5
Leukemic
6 day
3.9
5.4
15.1
1.0
25.4
73.0
1.0
Experimental**
Leukemic
8 day
2.4
6.9
26.3
1.0
36.6
63.0
1.0
Leukemic
12 day
6.8
10.5
22.1
2.0
41.4
45.0
1.0
Leukemic
18 day
2.9
15.5
50.1
1.0
69.5
30.0
1.0
*Scarborough (1931), Petri (1933), as reported in Wintrobe, Clinical Hemology (1967).
**Percentage of differential leucocyte counts.
DISCUSSION
The histologic appearance of the sub-
cutaneous tumor arising from implanta-
tion of minced tumor into a normal host
appeared as a highly vacuolated mass of
rounded cells of variable size surrounded
by a dense connective tissue capsule.
Limited vascularization was apparent and
appeared distinct from the large number
of vacuoles. In previous studies, the
density of the tumor resulting from the
close packing of the cells appeared to
increase progressively throughout the
disease course (McMahon, 1972). The
vacuoles may represent localized necrosis.
Leukemic involvement of other organs
murine myelogenous leukemia as a tool
in the study of hematologic neoplasias.
Both the hematologic data and the
pathologic studies indicate that the
symptoms of leukemia are interwoven
with a marked inflammatory response by
the host mouse.
The erythrocyte and hematocrit counts
showed a consistent decrease as the dis-
ease progressed (fig. 2, left and center).
The red cell decrease was not gradual or
constant, however and the largest drop
occurred between the eighth- and twelfth-
day post-implantation. There was only
a small decrease in the erythrocyte count
from the twelfth to the eighteenth day.
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This is evidence that the fatigue and
weakness caused by anemia reaches its
peak near the twelfth day. It may be
noted in both figures that the range of
counts at a particular sampling time in-
creased progressively from 0 to 18 days
post-implantation.
The total leukocyte counts (fig. 2,
right), did not show a steady increase in
the number of cells as might be expected
in leukemia. Instead the counts at 6
days increased 50 percent over the con-
trol counts. Leukocyte count decreased
at the 8-day sampling point, and rose to
its peak at 12 days, only to decrease by
the eighteenth day. Cycling is possible
explanation for these readings. Cycling
is a phenomenon that has repeatedly been
observed in cases of leukemia. The
symptoms for each individual vary widely
and intermittent remissions of the dis-
ease have been frequently recorded.
Although cycling has not been previously
documented in studies of murine leu-
kemia, it has been known in human
leukemia for many years. Wintrobe
(1967) refers to a case where the leuko-
cyte count ranged from extreme leuko-
cytosis to leukopenia in three cycles in a
period of 30 months.
Besides the cycling, which was evident
in the peripheral blood counts, two
major causes of death are postulated
from our study of the number of deaths
on each of the days post-implantation
(fig. 1). Note that the number of deaths
did not follow the characteristic unimodal
bell curve. Instead two modes were
found, one at 12 days and one at 16
days. Coupled with this was the obser-
vation that nearly all of the mice dying
on or before the thirteenth day were
comparatively healthy. In these mice a
tumor was usually evident, but the fur
was shiny and they were generally
active. The mice that survived to the
sixteenth day and beyond were puffy,
had noticeable infections, showed little
activity and generally appeared very
sickly. Comparing survival data with the
observed erythrocyte, hematocrit and
leukocyte counts, it appeared that the
deaths which occur at the twelfth-day
day peak were primarily attributable to
anemia. Those mice which had suf-
ficient red cells to survive this crisis,
succumbed to secondary infection or
failure of a vital organ due to infiltration
by leukemic cells.
Cycling was evident in the differential
white cell counts where the largest num-
bers of immature granulocytes (both
early and intermediate) occurred at 6
and 12 days with a moderate elevation at
18 days (fig. 3, top and center). An in-
teresting, and rather unexpected, trend
was the elevation of mature granulocytes
in the blood throughout the course of the
disease (fig. 3, bottom). It appears that
the difficulty was not so much that there
are too few mature granulocytes to meet
the demands of the individual but that
the presence of additional large numbers
of immature granulocytes disrupted
proper function of the phagocytic and,
perhaps, immune mechanisms. The large
number of mature granulocytes may
have resulted from the marrow storage
compartment pouring cells into the
peripheral blood in response to the ab-
normally high percentage of immature
granulocytes and the onset of infection,
or to increased granulopoiesis which is
suggested by the timing of the increase.
The percentage of lymphocytes dropped
markedly as would be expected with the
onset of myeloid leukemia, however, the
absolute cell count of lymphocytes was
increased over the value for normal mice
at 6, 8 and 12 days (fig. 4, bottom). The
only significant increase in the absolute
count of eosinophils was at 12 days
(fig. 4, top).
The fibrous capsule surrounding the
tumor and the low vascularity of the
tumor tissue coupled with intense vacu-
olation suggest that the host animal
walled off the "foreign" tissue with an
intense rejection response. This was ap-
parent, although the transplanted tumor
cells came from isologous and highly
inbred C57B1/6J mice raised under
identical conditions in our laboratory
for three years. The walling off of the
tumor tissue accompanied the marked
neutrophilia evident in the blood (table
1), suggesting that the unusual charac-
teristics of the C1498 myelogenous leu-
kemia may have been due to the host's
response to the tumor implant rather
than a true leukemia. This possibility is
enhanced by the high level of mature
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granulocytes (Table 1) found in the
"leukemic" animals. The increase in
immature granulocytes formed progres-
sively during the disease course may have
been due to the increased granulopoiesis
taking place in the bone marrow. This
would appear to be a classic "shift-to-
the-left" normally seen in the response
to acute infection.
Granulocyte infiltration in the spleen
and liver was present as expected in any
massive response to infection as well as
in a true myelogenous leukemia but no
thymic involvement was seen. Possibly
the recipient C57B1/6J mice had an in-
creased recognition of the tumor cells as
"foreign" and hence, granulocytic and
immune response to the invading cells
increased.
The demonstration of "C-type par-
ticles," the ability to maintain the "dis-
ease" as an ascites tumor by intraperi-
toneal injection, and the ability to cause
the development of the leukemia by in-jection of cells isolated from peripheral
blood all support the original identifica-
tion of the C1498 transplantable tumor
as a leukemia. It is suggested that the
characteristics of a true myelogenous
leukemia are masked by the presence of a
massive neutrophilic inflammatory re-
sponse on the part of the host mouse.
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